Search
Verastem Inc
VSTMAdd to Watchlist
8.180USD
-0.260-3.08%
Close 11-13 16:00（ET）
993.22MMarket Cap
LossP/E TTM
Verastem Inc (VSTM) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to Verastem Inc in the past month.
Buy
4 Strong Buy
6 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
17.222USD+76.64%
VSTM Analyst Recommendation Trends
In the current month, VSTM has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VSTM average Analyst price target in the last month is 17.222.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
3
3
3
3
3
3
6
6
6
6
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
9
9
9
9
9
9
VSTM Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, VSTM EPS is projected to reach -0.493 in FY2026Q4, following reported EPS of -0.738 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.46
-0.43
-0.46
-0.49
-0.60
Actual
-0.37
-0.35
-0.74
--
--
Surprise
+19.27%
+19.96%
-60.81%
--
--
FAQs
What is Verastem Inc's expected revenue for the next quarter?
Verastem Inc's expected revenue is 26.82M.
What is Verastem Inc's price target?
Analysts forecast that Verastem Inc's price target is USD 17.22, with the highest forecast at USD 24.00 and the lowest forecast at USD 12.00.
How have Verastem IncVSTM's recent earnings per share performed?
The market expectation was USD -0.74, while Verastem IncVSTM's earnings per share (EPS) for the previous quarter was USD -0.35. EPS for the next quarter is expected at USD -0.49.
What is the analyst rating for Verastem Inc?
Based on the ratings of Verastem Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.